| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Mark C Fisher | |
| Sheila L Arvikar | |||
| P2860 | cites work | The genetic basis of spondyloarthritis | Q83456495 |
| A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease | Q22251291 | ||
| Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease | Q27860821 | ||
| Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial | Q28202166 | ||
| Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial | Q28202504 | ||
| An association between ulcerative colitis, regional enteritis, and ankylosing spondylitis | Q78763423 | ||
| The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease | Q79687965 | ||
| A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations | Q80243465 | ||
| The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States | Q81372707 | ||
| Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis | Q82665747 | ||
| A genome-wide association study identifies IL23R as an inflammatory bowel disease gene | Q28270603 | ||
| Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences | Q29617565 | ||
| Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease | Q33551336 | ||
| Arthritis and Crohn's disease. A family study | Q33568709 | ||
| HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. | Q33578883 | ||
| The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease | Q33600367 | ||
| ARTHRITIC MANIFESTATIONS IN REGIONAL ENTERITIS | Q33626188 | ||
| Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease | Q33769709 | ||
| Infliximab for the treatment of fistulas in patients with Crohn's disease | Q33860666 | ||
| The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy | Q34016674 | ||
| Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria | Q34055060 | ||
| Sacroiliitis is common in Crohn's disease patients with perianal or upper gastrointestinal involvement | Q34206667 | ||
| Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial | Q34568678 | ||
| Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial | Q34574245 | ||
| Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept | Q34628130 | ||
| Arthritic manifestations of inflammatory bowel disease | Q34655379 | ||
| Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature | Q35052859 | ||
| Ulcerative colitis in Kuwait: a review of 90 cases | Q35215975 | ||
| Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history | Q35349708 | ||
| Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations | Q35553741 | ||
| CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease | Q35555605 | ||
| Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab | Q35751085 | ||
| Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes | Q35954535 | ||
| The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats | Q36364133 | ||
| Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases | Q36502842 | ||
| Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. | Q37240622 | ||
| Joint expedition: linking gut inflammation to arthritis | Q37349737 | ||
| Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion | Q37366534 | ||
| Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group | Q37488924 | ||
| Imaging of axial spondyloarthritis including ankylosing spondylitis | Q37845583 | ||
| Assessing response and loss of response to biological therapies in IBD. | Q37856191 | ||
| Methotrexate: a drug of the future in ulcerative colitis? | Q37861855 | ||
| Identical T-cell expansions in the colon mucosa and the synovium of a patient with enterogenic spondyloarthropathy | Q38463115 | ||
| Clinical patterns of Crohn's disease in Greece: a follow-up study of 155 cases | Q39530663 | ||
| Clinical History as a Screening Test for Ankylosing Spondylitis | Q39812250 | ||
| Severe ulcerative colitis after rituximab therapy | Q40355926 | ||
| Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice | Q40705435 | ||
| Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules | Q40820372 | ||
| Fibromyalgia in inflammatory bowel disease. | Q41665945 | ||
| Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis | Q42694138 | ||
| Fibromyalgia in patients with rheumatoid arthritis is associated with higher scores of disability. | Q42719027 | ||
| Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163. | Q43049211 | ||
| Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions | Q43986034 | ||
| Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). | Q44033784 | ||
| Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis | Q44358134 | ||
| Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab | Q44742543 | ||
| Arthritis related to ileal pouchitis following total proctocolectomy for ulcerative colitis | Q44962943 | ||
| Exacerbation of ulcerative colitis after rituximab salvage therapy | Q45226801 | ||
| Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort | Q45896089 | ||
| Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial | Q46688826 | ||
| Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study | Q46937246 | ||
| Clinical and genetic factors associated with sacroiliitis in Crohn's disease | Q49045190 | ||
| Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy | Q49051261 | ||
| Long-term evolution of gut inflammation in patients with spondyloarthropathy | Q49100255 | ||
| Subclinical involvement of the gut in undifferentiated spondylarthropathies | Q49129563 | ||
| Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association | Q49168509 | ||
| Asymptomatic sacroiliitis in inflammatory bowel disease. Assessment by computed tomography. | Q51041684 | ||
| Peripheral arthritis in the course of inflammatory bowel diseases. | Q51566345 | ||
| Ileal pouchitis and arthritis. | Q51722469 | ||
| Articular manifestations in inflammatory bowel disease patients: a prospective study. | Q51773346 | ||
| Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. | Q51821980 | ||
| The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. | Q51842478 | ||
| Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia. | Q51941582 | ||
| New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). | Q52913338 | ||
| SACRO-ILIITIS AND ULCERATIVE COLITIS. | Q53032294 | ||
| THE ARTHRITIS OF ULCERATIVE COLITIS. | Q53032298 | ||
| Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. | Q53050152 | ||
| The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy | Q53061383 | ||
| Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease. | Q53657692 | ||
| HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. | Q53663069 | ||
| The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). | Q55035528 | ||
| CTLA4 -1661A/G and 3'UTR long repeat polymorphisms are associated with ulcerative colitis and influence CTLA4 mRNA and protein expression | Q56899384 | ||
| A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease | Q56992312 | ||
| Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations | Q57436454 | ||
| Role ofNOD2 variants in spondylarthritis | Q57667873 | ||
| Association of interleukin-23 receptor variants with ankylosing spondylitis | Q57674028 | ||
| Musculoskeletal Manifestations in a Population-based Cohort of Inflammatory Bowel Disease Patients | Q58854739 | ||
| Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines1 | Q59705230 | ||
| The spondylitis of inflammatory bowel disease. Evidence for a non-HLA linked axial arthropathy | Q70538809 | ||
| Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients | Q71603762 | ||
| Joint symptoms after restorative proctocolectomy in ulcerative colitis and familial polyposis coli | Q71603765 | ||
| Intestinal and extraintestinal complications of Crohn's disease: predictors and cumulative probability of complications | Q71986467 | ||
| Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms | Q73299268 | ||
| Subclinical sacroiliitis in inflammatory bowel disease: a clinical and follow-up study | Q73370443 | ||
| Fibromyalgia and chronic widespread pain in patients with inflammatory bowel disease: a cross sectional population survey | Q73737653 | ||
| CARD15/NOD2 analyses in spondylarthropathy | Q74455368 | ||
| Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease | Q78389064 | ||
| P433 | issue | 3 | |
| P921 | main subject | inflammatory bowel diseases | Q917447 |
| P304 | page(s) | 123-131 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Current reviews in musculoskeletal medicine | Q26841992 |
| P1476 | title | Inflammatory bowel disease associated arthropathy | |
| P478 | volume | 4 |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q47392986 | Association of Inflammatory Bowel Disease with Arthritis: Evidence from In Silico Gene Expression Patterns and Network Topological Analysis. |
| Q38165235 | Diagnosing and treating psoriatic arthritis: an update |
| Q35924253 | Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study. |
| Q48365860 | Human microbiome, infections, and rheumatic disease |
| Q56966971 | IBD: IBD and spondyloarthritis: joint management |
| Q35434475 | Importance of intestinal microenvironment in development of arthritis. A systematic review |
| Q64266088 | Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment |
| Q36754750 | Intake of high-fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent arthritis in US adults, aged 20-30 years |
| Q87025205 | Involvement of IL-23 in enteropathic arthritis patients with inflammatory bowel disease: preliminary results |
| Q47638016 | Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study |
| Q40054186 | Management of patients with inflammatory bowel disease and spondyloarthritis |
| Q92051810 | Mechanisms Underlying Bone Loss Associated with Gut Inflammation |
| Q35762027 | Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases. |
| Q42614290 | Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model. |
| Q47140594 | Recent Research on Joint Pain and Arthritis in Patients With Inflammatory Bowel Disease |
| Q40447808 | Relationship between articular and nonarticular manifestations in inflammatory bowel diseases. |
| Q38634692 | Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology |
| Q89367074 | Rheumatic manifestations of inflammatory bowel diseases: A study from the Middle East |
| Q36309969 | Septic knee arthritis in Crohn's disease biological therapy-free patient. Case report |
| Q35557981 | Spondyloarthritis and the microbiome: new insights from an ancient hypothesis. |
| Q38438128 | Symptom management in inflammatory bowel disease |
| Q30241784 | The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis |
| Q64080168 | The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort |
| Q92611006 | Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics |
Search more.